Q4 2025 showcased the industry’s pivot toward precise biology, localised delivery, and earlier intervention – with multiple ...

There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College ...

First Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) ( ...

Nyxoah to Present at the 44 th Annual J.P. Morgan Healthcare Conference. Mont-Saint-Guibert, Belgium – December 29, 2025, ...

Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with ...

Brainsway ( ($BWAY) ) has provided an announcement. On December 22, 2025, BrainsWay Ltd. reported that Optum Behavioral Health, part of ...

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium - Dece ...

Nyxoah ( ($NYXH) ) has issued an update. On December 17, 2025, Nyxoah announced the commercial launch of its Genio hypoglossal neurostimulation ...

Inspire Medical (INSP) stock falls as the firm faces potential Medicare reimbursement cuts for its Gen 5 sleep apnea device ...

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...